NOVAVAX INC (NVAX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NVAX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NVAX | Former Senior Vice President, Corporate Development; Independent Director; Member | 73 | ["Industry Experience","Executive Leadership","Accounting, Financial or Investment Experience","Public Company Board","Former Senior Vice President, Corporate Development at Genzyme Corporation","Led Genzyme Corporation’s Corporate Development team","Involved in numerous acquisitions, licenses, financings, joint ventures, and strategic alliances","Served in science and corporate development capacities at Integrated Genetics","Postdoctoral fellow at the California Institute of Technology","Ph.D. in Biochemistry from University of California, Berkeley","Bachelor of Science in Chemistry from University of Michigan"] | ["Audit","Research & Development","Research and Development Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ALDX | Director | 73 | ["Senior Vice President, Corporate Development of Genzyme Corporation","Led Genzyme Corporation’s Corporate Development team from 1989 to 2011","Involved in numerous acquisitions, licenses, financings, joint ventures, and strategic alliances","Served in science and corporate development capacities at Integrated Genetics","Currently on the board of directors of Novavax, Inc.","Chairs the Board of Directors of MaxCyte, Inc.","Member of the University of Michigan Innovation Partnerships National Advisory Board","Advisor to Red Sky Partners LLC"] | [] | 2026 |